Clinical Trials in Boston

Showing 1021-1040 of 15,299 trials

Epcoritamab in Previously Treated WM

NCT06510491

This study is being done to determine if epcoritamab can be used to treat participants with previously treated Waldenstrom Macroglobulinemia (WM). The names of the study drug involved in this study is: -Epcoritamab (a type of antibody)

Waldenstrom MacroglobulinemiaB-Cell Lymphoproliferative Disorder

Gottfried von Keudell, MD PhD20 participantsStarted Dec 2024

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Chapel Hill, North Carolina, United States

Not Yet RecruitingNA< 1 mile

A Multi Center Study Testing a New Implant for Adults With Severe Emphysema

NCT07119229

A study taking place at multiple sites in the United States, Europe and Brazil to evaluate how well a new therapy for severe COPD/emphysema works, and how safe it is.

Emphysema or COPDEmphysemaCOPD

Pulmair Medical, Inc.60 participantsStarted Mar 2026

Chicago, Illinois, United States • Boston, Massachusetts, United States

Active Not RecruitingPhase 3< 1 mile

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD)

NCT05063162

The purpose of the study is to evalute the efficacy, safety and tolerability of rozanolixizumab for treatment of adult participants with myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOG-AD).

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)

UCB Biopharma SRL104 participantsStarted Feb 2022

Scottsdale, Arizona, United States • Palo Alto, California, United States • Aurora, Colorado, United States +70 more locations

Epcoritamab in Previously Treated WM

A Multi Center Study Testing a New Implant for Adults With Severe Emphysema

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD)

Find Trials by Condition in Boston

BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

A Study on Hydroxocobalamin Given to Healthy Individual to Monitor Symptoms

EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

Efficacy of Synchronous, Virtual Cognitive Behavioral Therapy for Insomnia Across Phases of Cancer Survivorship

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer

VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]

Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

Postpartum Preeclampsia Early Detection and Treatment: Nepal Pilot Study